Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprax for Late Onset Optic Neuropathy
NCT04469777Phase 2Completed
- Sponsor
- Alexandria University
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in optic neuropathy, sponsored by Alexandria University. Started Apr 2019; status: completed.
02
Drugs
epoetin alfa
03
Conditions
optic neuropathy
Beyond the preview
Go deeper on NCT04469777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469777.